What Can You Expect at the Only LNP-Dedicated Forum?

The LNP field is entering a new phase of growth as developers move beyond vaccines and into gene editing, genetic medicines, oncology, and in vivo cell therapies. As more programs progress towards the clinic, the challenge is no longer proving the potential of LNPs, but designing targeted, scalable, and manufacturable products that can succeed in development and beyond.

The 6th Lipid Nanoparticles Summit US brings together the formulation, analytical development, extra-hepatic delivery, process development, and CMC communities in one flagship meeting for the first time, helping attendees tackle the key scientific and operational challenges shaping the future of LNP therapeutics. This is the world’s definitive LNP summit and if you’re working in this field, you need to be there this March.

76279 - Compressed Event photos

Three Specialist Communities. One End-to-End Development Conversation – Divide & Conquer:

Formulation & Process Development Teams

 

Develop safer, more effective, and scalable LNPs by exploring lipid selection, formulation design, intracellular trafficking, targeting strategies, stability, and manufacturing scale-up. Gain direct insight into how analytical and extra-hepatic delivery considerations can be built into development decisions earlier, reducing costly downstream challenges.

Expert Speakers Include:

Sorry, we couldn't find any posts. Please try a different search.

Umberto Capasso Palmiero

Amey Bandekar

Mark Hayes

Analytical Development & Characterization Teams

 

Strengthen your ability to characterize increasingly complex LNPs through advanced analytical methods, potency assessment, single-particle characterization, and stability evaluation. Connect analytical data to formulation, manufacturing, and extra-hepatic delivery outcomes to generate stronger evidence, increase confidence in development decisions, and support regulatory progression.

Expert Speakers Include: 

Anastasiya Manuilov

Ankit Kanth

Zichuan Zhang

Extra-Hepatic Delivery Teams

 

Stay at the forefront of the next wave of LNP innovation through tissue-specific targeting, liver de-targeting, ligand engineering, and delivery validation strategies. Learn how innovators are translating targeted LNP concepts into clinically relevant therapies, while gaining exposure to the formulation, analytical, and manufacturing foundations needed to support successful development.

Expert Speakers Include:

Liping Zhou

Kevin Tan

Cangjie Yang

Explore the Preliminary Event Guide

  • Explore exclusive insights and sessions covering formulation, extra-hepatic delivery, analytical development, and CMC
  • Discover the latest strategies for targeted delivery, proving tissue-specific uptake, and advancing beyond the liver
  • Preview case studies from leading organizations including GSK, Sanofi, AbbVie, AstraZeneca, and ModeX Therapeutics
  • Discover practical insights on scaling LNPs from discovery through clinical development and commercial manufacturing
  • Share with colleagues to evaluate the content streams, sessions, speakers, and networking opportunities most relevant to your team
LNP Summit US conference brochure download graphic featuring the event brochure cover, agenda preview, event highlights, speaker line-up, and conference information pages stacked to showcase downloadable event content.

Attending Companies Include

9

Explore the Preliminary Agenda

Discover the latest advances in targeted delivery, analytical development, process scale-up, and CMC readiness through expert-led presentations, interactive discussions, and real-world case studies from leading LNP developers.

10

Partner With Us

Position your organization at the heart of the LNP community and connect with formulation, analytical, delivery, process development, and CMC leaders actively seeking solutions to accelerate their pipelines and overcome development challenges.

8

Join LNP Leaders

Connect with scientists and decision-makers from organizations including GSK, Sanofi, AbbVie, AstraZeneca, Alnylam Pharmaceuticals, and Bristol Myers Squibb, and build relationships across the full LNP development ecosystem during dedicated networking opportunities.